시장조사 보고서 : 세계의 바이러스 벡터 및 플라스미드 DNA 제조 시장예측 2021년-2026년

■ 영문 제목 : Global Viral Vectors and Plasmid DNA Manufacturing Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02331 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 114 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 바이러스 벡터 및 플라스미드 DNA 제조의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (플라스미드 DNA, 바이러스 벡터)와 용도별 시장규모 (암, 유전성 질환, 바이러스 감염증, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 바이러스 벡터 및 플라스미드 DNA 제조 시장 점유율
- 지역별 바이러스 벡터 및 플라스미드 DNA 제조 시장규모
- 주요지역의 종류별 시장규모 (플라스미드 DNA, 바이러스 벡터)
- 주요지역의 용도별 시장규모 (암, 유전성 질환, 바이러스 감염증, 기타)
- 미주의 바이러스 벡터 및 플라스미드 DNA 제조 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 바이러스 벡터 및 플라스미드 DNA 제조 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 바이러스 벡터 및 플라스미드 DNA 제조 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 바이러스 벡터 및 플라스미드 DNA 제조 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 바이러스 벡터 및 플라스미드 DNA 제조 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Viral Vectors and Plasmid DNA Manufacturing will have significant change from previous year. By the most conservative estimates of global Viral Vectors and Plasmid DNA Manufacturing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 502.8 million in 2020. Over the next five years the Viral Vectors and Plasmid DNA Manufacturing market will register a 18.7% CAGR in terms of revenue, the global market size will reach US$ 997.3 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vectors and Plasmid DNA Manufacturing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Plasmid DNA
Viral Vectors

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cancers
Inherited Disorders
Viral Infections
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size 2016-2026
2.1.2 Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Type
2.2.1 Plasmid DNA
2.2.2 Plasmid DNA
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
2.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Type
2.3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2016-2021)
2.4 Viral Vectors and Plasmid DNA Manufacturing Segment by Application
2.4.1 Cancers
2.4.2 Inherited Disorders
2.4.3 Viral Infections
2.4.4 Others
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
2.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Application
2.5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2016-2021)

3 Viral Vectors and Plasmid DNA Manufacturing Market Size by Players
3.1 Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Players
3.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2019-2021E)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2019-2021E)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Viral Vectors and Plasmid DNA Manufacturing by Regions
4.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions (2016-2021)
4.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2016-2021)
4.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2016-2021)
4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2016-2021)
4.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2016-2021)

5 Americas
5.1 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2016-2021)
5.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021)
5.3 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2016-2021)
6.2 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021)
6.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing by Country (2016-2021)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021)
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing by Region (2016-2021)
8.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021)
8.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.1 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions (2021-2026)
10.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions (2021-2026)
10.1.2 Americas Viral Vectors and Plasmid DNA Manufacturing Forecast
10.1.3 APAC Viral Vectors and Plasmid DNA Manufacturing Forecast
10.1.4 Europe Viral Vectors and Plasmid DNA Manufacturing Forecast
10.1.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Forecast
10.2 Americas Viral Vectors and Plasmid DNA Manufacturing Forecast by Countries (2021-2026)
10.2.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.2.2 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.2.3 Mexico Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.2.4 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.3 APAC Viral Vectors and Plasmid DNA Manufacturing Forecast by Region (2021-2026)
10.3.1 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.3.2 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.3.3 Korea Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.3.4 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.3.5 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.3.6 Australia Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.4 Europe Viral Vectors and Plasmid DNA Manufacturing Forecast by Country (2021-2026)
10.4.1 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.4.2 France Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.4.3 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.4.4 Italy Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.4.5 Russia Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Forecast by Region (2021-2026)
10.5.1 Egypt Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.5.2 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.5.3 Israel Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.5.4 Turkey Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.5.5 GCC Countries Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.6 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Type (2021-2026)
10.7 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 BioReliance
11.1.1 BioReliance Company Information
11.1.2 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 BioReliance Main Business Overview
11.1.5 BioReliance Latest Developments
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Information
11.2.2 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Cobra Biologics Main Business Overview
11.2.5 Cobra Biologics Latest Developments
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Information
11.3.2 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Oxford BioMedica Main Business Overview
11.3.5 Oxford BioMedica Latest Developments
11.4 UniQure
11.4.1 UniQure Company Information
11.4.2 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 UniQure Main Business Overview
11.4.5 UniQure Latest Developments
11.5 FinVector
11.5.1 FinVector Company Information
11.5.2 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 FinVector Main Business Overview
11.5.5 FinVector Latest Developments
11.6 MolMed
11.6.1 MolMed Company Information
11.6.2 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 MolMed Main Business Overview
11.6.5 MolMed Latest Developments
11.7 MassBiologics
11.7.1 MassBiologics Company Information
11.7.2 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 MassBiologics Main Business Overview
11.7.5 MassBiologics Latest Developments
11.8 Richter-Helm
11.8.1 Richter-Helm Company Information
11.8.2 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Richter-Helm Main Business Overview
11.8.5 Richter-Helm Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
11.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Lonza
11.10.1 Lonza Company Information
11.10.2 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Lonza Main Business Overview
11.10.5 Lonza Latest Developments
11. Aldevron
11.11.1 Aldevron Company Information
11.11.2 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Aldevron Main Business Overview
11.11.5 Aldevron Latest Developments
11.12 Eurogentec
11.12.1 Eurogentec Company Information
11.12.2 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Eurogentec Main Business Overview
11.12.5 Eurogentec Latest Developments
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Information
11.13.2 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Cell and Gene Therapy Catapult Main Business Overview
11.13.5 Cell and Gene Therapy Catapult Latest Developments
11.14 Biovian
11.14.1 Biovian Company Information
11.14.2 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Biovian Main Business Overview
11.14.5 Biovian Latest Developments
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Information
11.15.2 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Thermo Fisher Scientific (Brammer Bio) Main Business Overview
11.15.5 Thermo Fisher Scientific (Brammer Bio) Latest Developments
11.16 VGXI
11.16.1 VGXI Company Information
11.16.2 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 VGXI Main Business Overview
11.16.5 VGXI Latest Developments
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Information
11.17.2 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Offered
11.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 PlasmidFactory Main Business Overview
11.17.5 PlasmidFactory Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Plasmid DNA
Table 3. Major Players of Viral Vectors
Table 4. Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2016-2021)
Table 7. Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2016-2021)
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2019-2021E)
Table 12. Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Products Offered
Table 13. Viral Vectors and Plasmid DNA Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Regions 2016-2021
Table 18. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Country (2016-2021)
Table 20. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2016-2021)
Table 22. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2016-2021)
Table 24. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Region (2016-2021)
Table 26. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2016-2021)
Table 28. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2016-2021)
Table 30. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Country (2016-2021)
Table 32. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2016-2021)
Table 34. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Viral Vectors and Plasmid DNA Manufacturing
Table 43. Key Application and Potential Industries of Viral Vectors and Plasmid DNA Manufacturing
Table 44. Key Challenges of Viral Vectors and Plasmid DNA Manufacturing
Table 45. Key Trends of Viral Vectors and Plasmid DNA Manufacturing
Table 46. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Application (2021-2026)
Table 52. BioReliance Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 53. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 54. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. BioReliance Main Business
Table 56. BioReliance Latest Developments
Table 57. Cobra Biologics Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 58. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 59. Cobra Biologics Main Business
Table 60. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Cobra Biologics Latest Developments
Table 62. Oxford BioMedica Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 63. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 64. Oxford BioMedica Main Business
Table 65. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Oxford BioMedica Latest Developments
Table 67. UniQure Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 68. UniQure Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 69. UniQure Main Business
Table 70. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. UniQure Latest Developments
Table 72. FinVector Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 73. FinVector Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 74. FinVector Main Business
Table 75. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. FinVector Latest Developments
Table 77. MolMed Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 78. MolMed Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 79. MolMed Main Business
Table 80. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. MolMed Latest Developments
Table 82. MassBiologics Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 83. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 84. MassBiologics Main Business
Table 85. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. MassBiologics Latest Developments
Table 87. Richter-Helm Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 88. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 89. Richter-Helm Main Business
Table 90. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Richter-Helm Latest Developments
Table 92. FUJIFILM Diosynth Biotechnologies Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 93. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 94. FUJIFILM Diosynth Biotechnologies Main Business
Table 95. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 97. Lonza Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 98. Lonza Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 99. Lonza Main Business
Table 100. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Lonza Latest Developments
Table 102. Aldevron Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 103. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 104. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Aldevron Main Business
Table 106. Aldevron Latest Developments
Table 107. Eurogentec Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 108. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 109. Eurogentec Main Business
Table 110. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. Eurogentec Latest Developments
Table 112. Cell and Gene Therapy Catapult Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 113. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 114. Cell and Gene Therapy Catapult Main Business
Table 115. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. Cell and Gene Therapy Catapult Latest Developments
Table 117. Biovian Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 118. Biovian Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 119. Biovian Main Business
Table 120. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Biovian Latest Developments
Table 122. Thermo Fisher Scientific (Brammer Bio) Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 123. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 124. Thermo Fisher Scientific (Brammer Bio) Main Business
Table 125. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Thermo Fisher Scientific (Brammer Bio) Latest Developments
Table 127. VGXI Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 128. VGXI Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 129. VGXI Main Business
Table 130. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. VGXI Latest Developments
Table 132. PlasmidFactory Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 133. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 134. PlasmidFactory Main Business
Table 135. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. PlasmidFactory Latest Developments
List of Figures
Figure 1. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2020
Figure 7. Viral Vectors and Plasmid DNA Manufacturing in Cancers
Figure 8. Global Viral Vectors and Plasmid DNA Manufacturing Market: Cancers (2016-2021) & ($ Millions)
Figure 9. Viral Vectors and Plasmid DNA Manufacturing in Inherited Disorders
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market: Inherited Disorders (2016-2021) & ($ Millions)
Figure 11. Viral Vectors and Plasmid DNA Manufacturing in Viral Infections
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market: Viral Infections (2016-2021) & ($ Millions)
Figure 13. Viral Vectors and Plasmid DNA Manufacturing in Others
Figure 14. Global Viral Vectors and Plasmid DNA Manufacturing Market: Others (2016-2021) & ($ Millions)
Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2020
Figure 16. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Player in 2020
Figure 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size 2016-2021 ($ Millions)
Figure 19. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size 2016-2021 ($ Millions)
Figure 20. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2016-2021 ($ Millions)
Figure 22. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Country in 2020
Figure 23. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2020
Figure 24. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2020
Figure 25. United States Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Regions in 2020
Figure 29. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2020
Figure 30. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2020
Figure 31. China Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Country in 2020
Figure 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2020
Figure 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2020
Figure 40. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2020
Figure 48. Egypt Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 54. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 55. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 57. United States Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 58. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 61. China Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 62. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 63. Korea Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 65. India Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 66. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 67. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 68. France Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 69. UK Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 70. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 71. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 72. Spain Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 75. Israel Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Viral Vectors and Plasmid DNA Manufacturing Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 바이러스 벡터 및 플라스미드 DNA 제조 시장예측 2021년-2026년] (코드 : LPI-2201K02331) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 바이러스 벡터 및 플라스미드 DNA 제조 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 바이러스 벡터 및 플라스미드 DNA 시장예측 2021년-2026년
LPI-2201K02330 / LP Information / 2021년 12월 / 본 조사보고서는 바이러스 벡터 및 플라스미드 DNA의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Viral Vector and Plasmid DNA will have significant change from previous year. By the most conservative estimates of global Viral Vector and Plasmid DNA market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 바이러스 진단 검사 키트 시장예측 2021년-2026년
LPI-2201K02700 / LP Information / 2021년 12월 / 본 조사보고서는 바이러스 진단 검사 키트의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Viral Diagnostic Test Kits will have significant change from previous year. By the most conservative estimates of global Viral Diagnostic Test Kits market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 바이러스 및 박테리아 필터 시장예측 2021년-2026년
LPI-2201K02699 / LP Information / 2021년 12월 / 본 조사보고서는 바이러스 및 박테리아 필터의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Viral And Bacterial Filters will have significant change from previous year. By the most conservative estimates of global Viral And Bacterial Filters market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 종양 용해성 바이러스 치료 시장예측 2021년-2026년
LPI-2201K02250 / LP Information / 2021년 12월 / 본 조사보고서는 종양 용해성 바이러스 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Oncolytic Virus Therapy will have significant change from previous year. By the most conservative estimates of global Oncolytic Virus Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5 million in...

세계의 인간 유두종 바이러스 (HPV) 검사 시장예측 2021년-2026년
LPI-2201K00137 / LP Information / 2021년 12월 / 본 조사보고서는 인간 유두종 바이러스 (HPV) 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Human Papillomavirus (HPV) Testing will have significant change from previous year. By the most conservative estimates of global Human Papillomavirus (HPV) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 C형 간염 바이러스 (HCV) 항바이러스제 시장예측 2021년-2026년
LPI-2201K00122 / LP Information / 2021년 12월 / 본 조사보고서는 C형 간염 바이러스 (HCV) 항바이러스제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Hepatitis C Virus (HCV) Antiviral will have significant change from previous year. By the most conservative estimates of global Hepatitis C Virus (HCV) Antiviral market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...